<html>
  <head></head>
  <body>
    <div id="contentsscroll">
      <table border="0" cellpadding="0" cellspacing="0" width="100%">
        <tbody>
          <tr>
            <td class="sizetext1" valign="top">
              B.C. Reg. 222/2014
              <br />
              <span class="sizetext2"> O.C. 661/2014 </span>
            </td>
            <td align="right" class="sizetext1" valign="top">
              Deposited November 27, 2014
              <br />
              <span class="sizetext2"> effective December 1, 2014 </span>
            </td>
          </tr>
        </tbody>
      </table>
      <span class="regCurrency">
        <strong> This consolidation is current to March 5, 2024. </strong>
      </span>
      <h5 align="center">
        <strong>
          <a
            href="/civix/content/crbc/crbc/1922970521/370494221/222_2014_dir/?xsl=/templates/browse.xsl"
          >
            Link to consolidated regulation (PDF)
          </a>
        </strong>
      </h5>
      <h5 align="center">
        <strong>
          <a href="/civix/document/id/complete/statreg/222_2014_pit">
            Link to Point in Time
          </a>
        </strong>
      </h5>
      <div id="actname">
        <h2>Pharmaceutical Services Act</h2>
      </div>
      <div id="title">
        <h2>Provider Regulation</h2>
      </div>
      <p align="center">[Last amended March 30, 2022 by B.C. Reg. 76/2022]</p>
      <p align="center"></p>
      <p class="part" id="d1e33">
        <a name="part1"> </a>
        Part 1 — Definitions
      </p>
      <div class="section">
        <a name="section1"> </a>
        <h4>
          <a name="section1"> </a>
          Definitions
        </h4>
        <p class="sec nosubsecnum" id="d1e41">
          <span class="secnum">
            <span class="secnumholder">
              <b> 1 </b>
            </span>
          </span>
          In this regulation:
        </p>
        <p class="def" id="d1e52">
          <span class="normal-bold-style" id="Act"> "Act" </span>
          means the
          <a href="/civix/document/id/complete/statreg/12022_01">
            <em> Pharmaceutical Services Act </em>
          </a>
          ;
        </p>
        <p class="def" id="d1e60">
          <span class="normal-bold-style" id="applicant"> "applicant" </span>
          means an applicant for enrolment as a provider;
        </p>
        <p class="def" id="d1e69">
          <span class="normal-bold-style" id="billing+privileges">
            "billing privileges"
          </span>
          means the privilege of seeking payment for the provision to another
          person of drugs, devices, substances or related services directly from
        </p>
        <p class="para">
          <a name="d1e76"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          the minister, whether the privilege is granted under the Act or
          further to a policy made in relation to the
          <a href="/civix/document/id/complete/statreg/96070_01">
            <em> Continuing Care Act </em>
          </a>
          , the
          <a href="/civix/document/id/complete/statreg/03077_01">
            <em> Pharmacy Operations and Drug Scheduling Act </em>
          </a>
          or the
          <a href="/civix/document/id/complete/statreg/96363TC_01">
            <em> Pharmacists, Pharmacy Operations and Drug Scheduling Act </em>
          </a>
          , or
        </p>
        <p class="para">
          <a name="d1e85"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          in the case of a public drug insurance program, the public insurer
          through which the program is delivered;
        </p>
        <p class="def" id="d1e95">
          <span class="normal-bold-style" id="class"> "class" </span>
          means a class of provider established by the minister under
          section&nbsp;11&nbsp;(4)&nbsp;(b)
          <em> [enrolment of providers] </em>
          of the Act, those classes being the following:
        </p>
        <p class="para">
          <a name="d1e102"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          pharmacy provider, which includes the sub-classes of Plan B provider
          and opioid agonist treatment provider;
        </p>
        <p class="para">
          <a name="d1e111"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          device provider, which includes the sub-classes of compression garment
          provider, limb prosthesis provider, breast prosthesis provider, ocular
          prosthesis provider, orthosis provider and any other sub-classes
          established by the minister;
        </p>
        <p class="def" id="d1e121">
          <span class="normal-bold-style" id="College+of+Pharmacists+bylaws">
            "College of Pharmacists bylaws"
          </span>
          means those bylaws of the College of Pharmacists of British Columbia
          made under the authority of the
          <a href="/civix/document/id/complete/statreg/96183_01">
            <em> Health Professions Act </em>
          </a>
          ;
        </p>
        <p class="def" id="d1e129">
          <span class="normal-bold-style" id="extrajurisdictional+applicant">
            "extrajurisdictional applicant"
          </span>
          or
          <span class="normal-bold-style" id="extrajurisdictional+provider">
            "extrajurisdictional provider"
          </span>
          means an applicant or a provider, as applicable, having as the subject
          of the person's application or enrolment a site outside British
          Columbia but inside Canada;
        </p>
        <p class="def" id="d1e137">
          <span class="normal-bold-style" id="First+Nations+Health+Authority">
            "First Nations Health Authority"
          </span>
          means the First Nations Health Authority, a society under the
          <a href="/civix/document/id/complete/statreg/15018_01">
            <em> Societies Act </em>
          </a>
          ;
        </p>
        <p class="def" id="d1e145">
          <span class="normal-bold-style" id="FNHB+program">
            "FNHB program"
          </span>
          means the First Nations Health Benefits Program delivered through the
          First Nations Health Authority for the purpose of providing, to First
          Nations individuals who are residents of British Columbia, financial
          assistance for health-related goods and services;
        </p>
        <p class="def" id="d1e154">
          <span class="normal-bold-style" id="governing+body">
            "governing body"
          </span>
          means the following, as applicable:
        </p>
        <p class="para">
          <a name="d1e161"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          the College of Pharmacists of British Columbia;
        </p>
        <p class="para">
          <a name="d1e170"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          a body, in another province or territory or in a foreign jurisdiction,
          that regulates the practice of pharmacy in that other province,
          territory or foreign jurisdiction;
        </p>
        <p class="def" id="d1e180">
          <span class="normal-bold-style" id="identity+number">
            "identity number"
          </span>
          means the identity number referred to in section 15
          <em> [identity numbers] </em>
          of the Act;
        </p>
        <p class="def" id="d1e191">
          <span
            class="normal-bold-style"
            id="information+or+billing+contravention"
          >
            "information or billing contravention"
          </span>
          means a contravention of any of the following:
        </p>
        <p class="para">
          <a name="d1e198"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          a provision of a pharmacy enactment or a requirement of a public drug
          insurance program in relation to
        </p>
        <p class="subpara">
          <a name="d1e206"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          the provision of false, incomplete or misleading information,
        </p>
        <p class="subpara">
          <a name="d1e215"> </a>
          <span class="num">
            <span class="holder"> (ii) </span>
          </span>
          a failure to provide required information,
        </p>
        <p class="subpara">
          <a name="d1e224"> </a>
          <span class="num">
            <span class="holder"> (iii) </span>
          </span>
          the interference with or obstruction of a person who is exercising a
          power or performing a duty, or a person acting under the order or
          direction of that person, or
        </p>
        <p class="subpara">
          <a name="d1e234"> </a>
          <span class="num">
            <span class="holder"> (iv) </span>
          </span>
          a matter that resulted in the suspension or cancellation of billing
          privileges;
        </p>
        <p class="para">
          <a name="d1e244"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          a provision of an enactment of another jurisdiction of Canada that is
          equivalent to a pharmacy enactment, in relation to any of the matters
          set out in paragraph (a);
        </p>
        <p class="para">
          <a name="d1e253"> </a>
          <span class="num">
            <span class="holder"> (c) </span>
          </span>
          a provision of a pharmacy enactment, the
          <a href="/civix/document/id/complete/statreg/08038_01">
            <em>
              E-Health (Personal Health Information Access and Protection of
              Privacy) Act
            </em>
          </a>
          , the
          <a href="/civix/document/id/complete/statreg/96165_00">
            <em> Freedom of Information and Protection of Privacy Act </em>
          </a>
          , the
          <a href="/civix/document/id/complete/statreg/96183_01">
            <em> Health Professions Act </em>
          </a>
          , the
          <a href="/civix/document/id/complete/statreg/03063_01">
            <em> Personal Information Protection Act </em>
          </a>
          or a regulation made under any of them, in relation to the collection,
          use or disclosure of personal information;
        </p>
        <p class="def" id="d1e274">
          <span class="normal-bold-style" id="NIHB+program">
            "NIHB program"
          </span>
          means the Non-Insured Health Benefits Program delivered through Health
          Canada for the purpose of providing, to First Nations and Inuit
          individuals, financial assistance for health-related goods and
          services;
        </p>
        <p class="def" id="d1e263">
          <span
            class="normal-bold-style"
            id="opioid+agonist+treatment+services"
          >
            "opioid agonist treatment services"
          </span>
          means services provided by a pharmacist described in section
          3&nbsp;(4)
          <em> [enrolment of pharmacy providers] </em>
          in relation to the dispensing of a drug for opioid agonist treatment;
        </p>
        <p class="def" id="d1e282">
          <span class="normal-bold-style" id="owner"> "owner" </span>
          , in respect of
        </p>
        <p class="para">
          <a name="d1e289"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          a corporation and if applicable in the context, includes
        </p>
        <p class="subpara">
          <a name="d1e297"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          in the case of a corporation that is traded publicly, the officers and
          directors of the corporation, and
        </p>
        <p class="subpara">
          <a name="d1e306"> </a>
          <span class="num">
            <span class="holder"> (ii) </span>
          </span>
          in the case of a corporation that is not traded publicly,
        </p>
        <p class="clause">
          <a name="d1e314"> </a>
          <span class="num">
            <span class="holder"> (A) </span>
          </span>
          the officers, directors and shareholders of the corporation, and
        </p>
        <p class="clause">
          <a name="d1e323"> </a>
          <span class="num">
            <span class="holder"> (B) </span>
          </span>
          if a subsidiary corporation, the officers, directors and shareholders
          of the parent corporation, and
        </p>
        <p class="para">
          <a name="d1e334"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          a partnership and if applicable in the context, includes the partners
          of the partnership;
        </p>
        <p class="def" id="d1e345">
          <span class="normal-bold-style" id="partner"> "partner" </span>
          and
          <span class="normal-bold-style" id="partnership">
            "partnership"
          </span>
          have the same meaning as in the
          <a href="/civix/document/id/complete/statreg/96348_01">
            <em> Partnership Act </em>
          </a>
          ;
        </p>
        <p class="def" id="d1e364">
          <span
            class="normal-bold-style"
            id="Pharmacists,+Pharmacy+Operations+and+Drug+Scheduling+Act"
          >
            "
            <em> Pharmacists, Pharmacy Operations and Drug Scheduling Act </em>
            "
          </span>
          means the
          <a href="/civix/document/id/complete/statreg/96363TC_01">
            <em> Pharmacists, Pharmacy Operations and Drug Scheduling Act </em>
          </a>
          before it was amended by the
          <a href="/civix/document/id/complete/statreg/03077_01">
            <em> Pharmacy Operations and Drug Scheduling Act </em>
          </a>
          , S.B.C. 2003, c. 77;
        </p>
        <p class="def" id="d1e356">
          <span class="normal-bold-style" id="pharmacy+enactment">
            "pharmacy enactment"
          </span>
          means the Act, the
          <a href="/civix/document/id/complete/statreg/96070_01">
            <em> Continuing Care Act </em>
          </a>
          , the
          <a href="/civix/document/id/complete/statreg/96286_01">
            <em> Medicare Protection Act </em>
          </a>
          , the
          <a href="/civix/document/id/complete/statreg/03077_01">
            <em> Pharmacy Operations and Drug Scheduling Act </em>
          </a>
          , the
          <a href="/civix/document/id/complete/statreg/96363TC_01">
            <em> Pharmacists, Pharmacy Operations and Drug Scheduling Act </em>
          </a>
          or a regulation made under any of them;
        </p>
        <p class="def" id="d1e372">
          <span class="normal-bold-style" id="pharmacy+licence">
            "pharmacy licence"
          </span>
          means a community pharmacy licence or a hospital pharmacy licence
          issued in respect of a pharmacy under the
          <a href="/civix/document/id/complete/statreg/03077_01">
            <em> Pharmacy Operations and Drug Scheduling Act </em>
          </a>
          ;
        </p>
        <p class="def" id="d1e380">
          <span class="normal-bold-style" id="Plan+B"> "Plan B" </span>
          means the drug plan known as Plan B, as established under section 35
          of the Drug Plans Regulation;
        </p>
        <p class="def" id="d1e388">
          <span class="normal-bold-style" id="public+drug+insurance+program">
            "public drug insurance program"
          </span>
          means any of the following:
        </p>
        <p class="para">
          <a name="d1e395"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          the FNHB program;
        </p>
        <p class="para">
          <a name="d1e404"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          the NIHB program;
        </p>
        <p class="para">
          <a name="d1e413"> </a>
          <span class="num">
            <span class="holder"> (c) </span>
          </span>
          a public health insurance scheme delivered through a provincial or
          territorial government of Canada, other than the government of British
          Columbia, that provides to individuals financial assistance in respect
          of drugs, devices, substances or related services;
        </p>
        <p class="def" id="d1e424">
          <span class="normal-bold-style" id="public+insurer">
            "public insurer"
          </span>
          means any of the following:
        </p>
        <p class="para">
          <a name="d1e431"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          the First Nations Health Authority;
        </p>
        <p class="para">
          <a name="d1e440"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          the government of Canada;
        </p>
        <p class="para">
          <a name="d1e449"> </a>
          <span class="num">
            <span class="holder"> (c) </span>
          </span>
          a provincial or territorial government of Canada;
        </p>
        <p class="def" id="d1e459">
          <span class="normal-bold-style" id="site"> "site" </span>
          means
        </p>
        <p class="para">
          <a name="d1e466"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          a pharmacy,
        </p>
        <p class="para">
          <a name="d1e475"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          a site at which a person is authorized under an enactment of a
          province or territory, other than British Columbia, to store drugs or
          substances, or to dispense or sell drugs or substances to the public,
          or
        </p>
        <p class="para">
          <a name="d1e484"> </a>
          <span class="num">
            <span class="holder"> (c) </span>
          </span>
          a site through which devices are provided;
        </p>
        <p class="def" id="d1e494">
          <span class="normal-bold-style" id="site+identification+code">
            "site identification code"
          </span>
          means a unique code issued by the minister in respect of a specific
          site.
        </p>
        <p class="hnote">
          [am. B.C. Regs. 73/2015, App. 6; 211/2015, s. 29; 181/2019, Sch. s. 1;
          327/2021, s. 1; 76/2022, s. 4.]
        </p>
      </div>
      <p class="part" id="d1e504">
        <a name="part2"> </a>
        Part 2 — Enrolment
      </p>
      <div class="section">
        <a name="section2"> </a>
        <h4>
          <a name="section2"> </a>
          When not eligible for enrolment
        </h4>
        <p class="sec" id="d1e512">
          <span class="secnum">
            <span class="secnumholder">
              <b> 2 </b>
              <a name="d1e520"> </a>
              (1)
            </span>
          </span>
          This section applies to persons applying for enrolment in any provider
          class with respect to a particular site.
        </p>
        <p class="sub">
          <a name="d1e529"> </a>
          <span class="num">
            <span class="holder"> (2) </span>
          </span>
          An applicant is not eligible for enrolment if an owner or a manager of
          the site
        </p>
        <p class="para">
          <a name="d1e537"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          is required to pay an amount
        </p>
        <p class="subpara">
          <a name="d1e545"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          to the government as a result of an audit conducted under a pharmacy
          enactment, or
        </p>
        <p class="subpara">
          <a name="d1e554"> </a>
          <span class="num">
            <span class="holder"> (ii) </span>
          </span>
          to a public insurer as a result of an audit conducted in relation to
          the insurer's public drug insurance program,
        </p>
        <p class="para">
          <a name="d1e564"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          has been, or is, the subject of an order or a conviction for an
          information or billing contravention,
        </p>
        <p class="para">
          <a name="d1e573"> </a>
          <span class="num">
            <span class="holder"> (c) </span>
          </span>
          has the owner's or the manager's billing privileges suspended,
        </p>
        <p class="para">
          <a name="d1e583"> </a>
          <span class="num">
            <span class="holder"> (d) </span>
          </span>
          has had the owner's or the manager's billing privileges cancelled,
        </p>
        <p class="para">
          <a name="d1e592"> </a>
          <span class="num">
            <span class="holder"> (e) </span>
          </span>
          has been, or is, an owner or a manager of a site in respect of which
        </p>
        <p class="subpara">
          <a name="d1e600"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          an amount must be paid to the government as a result of an audit
          conducted under a pharmacy enactment,
        </p>
        <p class="subpara">
          <a name="d1e609"> </a>
          <span class="num">
            <span class="holder"> (ii) </span>
          </span>
          an amount must be paid to a public insurer as a result of an audit
          conducted in relation to the insurer's public drug insurance program,
        </p>
        <p class="subpara">
          <a name="d1e618"> </a>
          <span class="num">
            <span class="holder"> (iii) </span>
          </span>
          an order or a conviction for an information or billing contravention
          has been issued, or
        </p>
        <p class="subpara">
          <a name="d1e628"> </a>
          <span class="num">
            <span class="holder"> (iv) </span>
          </span>
          a person's billing privileges have been cancelled,
        </p>
        <p class="para sandwich">
          if the owner or manager was the owner or manager during the period for
          which the audit was conducted, at the time of the information or
          billing contravention, or at the time of the incident giving rise to
          the cancellation of billing privileges,
        </p>
        <p class="para">
          <a name="d1e641"> </a>
          <span class="num">
            <span class="holder"> (f) </span>
          </span>
          has, within the previous 6 years, had a judgment entered against the
          owner or the manager in a court proceeding related to commercial or
          business activities that occurred in relation to the provision of
          drugs, devices, substances or related services,
        </p>
        <p class="para">
          <a name="d1e650"> </a>
          <span class="num">
            <span class="holder"> (g) </span>
          </span>
          has, within the previous 6 years, been convicted of an offence
          prescribed under section 22 (1)
          <em> [suspension of payments] </em>
          ,
        </p>
        <p class="para">
          <a name="d1e662"> </a>
          <span class="num">
            <span class="holder"> (h) </span>
          </span>
          holds a pharmacy licence that is suspended, or has held a pharmacy
          licence that was suspended or cancelled,
        </p>
        <p class="para">
          <a name="d1e671"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          is an owner or a manager of a site in respect of which a person's
          billing privileges are suspended, or
        </p>
        <p class="para">
          <a name="d1e681"> </a>
          <span class="num">
            <span class="holder"> (j) </span>
          </span>
          has had the owner's or the manager's enrolment in any class of
          provider cancelled.
        </p>
        <p class="sub">
          <a name="d1e691"> </a>
          <span class="num">
            <span class="holder"> (3) </span>
          </span>
          An applicant is not eligible for enrolment if the applicant provides
          false or misleading information under section 7
          <em> [information required with application] </em>
          .
        </p>
        <p class="sub">
          <a name="d1e704"> </a>
          <span class="num">
            <span class="holder"> (4) </span>
          </span>
          An applicant is not eligible for enrolment in a sub-class if
        </p>
        <p class="para">
          <a name="d1e712"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          the applicant has been enrolled previously in the sub-class that is
          the subject of the application, and
        </p>
        <p class="para">
          <a name="d1e721"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          the applicant's billing privileges in relation to that sub-class were
          cancelled by the minister.
        </p>
        <p class="hnote">
          [am. B.C. Regs. 266/2016, Sch. 1, s. 1; 327/2021, s. 3; 76/2022, ss. 4
          and 5.]
        </p>
      </div>
      <div class="section">
        <a name="section3"> </a>
        <h4>
          <a name="section3"> </a>
          Enrolment of pharmacy providers
        </h4>
        <p class="sec" id="d1e732">
          <span class="secnum">
            <span class="secnumholder">
              <b> 3 </b>
              <a name="d1e740"> </a>
              (1)
            </span>
          </span>
          Without limiting section 2
          <em> [when not eligible for enrolment] </em>
          , this section applies to a person applying for enrolment within the
          pharmacy provider class with respect to a particular pharmacy.
        </p>
        <p class="sub">
          <a name="d1e752"> </a>
          <span class="num">
            <span class="holder"> (2) </span>
          </span>
          An applicant is not eligible for enrolment unless a pharmacy licence
          has been issued in respect of the pharmacy.
        </p>
        <p class="sub">
          <a name="d1e761"> </a>
          <span class="num">
            <span class="holder"> (3) </span>
          </span>
          An applicant is not eligible for enrolment if an owner or a manager of
          the pharmacy has had the owner's or the manager's registration with a
          governing body suspended or cancelled.
        </p>
        <p class="sub">
          <a name="d1e771"> </a>
          <span class="num">
            <span class="holder"> (4) </span>
          </span>
          An applicant is not eligible for enrolment in the opioid agonist
          treatment provider sub-class unless each pharmacist who will be
          providing drugs, devices, substances or related services through the
          pharmacy has successfully completed all relevant training, as required
          by the College of Pharmacists of British Columbia, with respect to
          opioid agonist treatment services.
        </p>
        <p class="sub">
          <a name="d1e905"> </a>
          <span class="num">
            <span class="holder"> (5) </span>
          </span>
          A provider who was enrolled in the methadone maintenance provider
          sub-class immediately before the date this section comes into force is
          deemed to be enrolled in the opioid agonist treatment provider
          sub-class.
        </p>
        <p class="hnote">
          [am. B.C. Regs. 181/2019, Sch. ss. 2 to 4; 327/2021, s. 3; 76/2022, s.
          4.]
        </p>
      </div>
      <div class="section">
        <a name="section3.1"> </a>
        <h4>
          <a name="section3.1"> </a>
          Repealed
        </h4>
        <p class="sec nosubsecnum" id="d1e918">
          <span class="secnum">
            <span class="secnumholder">
              <b> 3.1 </b>
            </span>
          </span>
          Repealed. [B.C. Reg. 222/2014, s. 3.1 (4).]
        </p>
      </div>
      <div class="section">
        <a name="section4"> </a>
        <h4>
          <a name="section4"> </a>
          Enrolment of device providers
        </h4>
        <p class="sec" id="d1e781">
          <span class="secnum">
            <span class="secnumholder">
              <b> 4 </b>
              <a name="d1e789"> </a>
              (1)
            </span>
          </span>
          Without limiting section 2
          <em> [when not eligible for enrolment] </em>
          , this section applies to a person applying for enrolment in the
          device provider class with respect to a particular site through which
          devices are provided.
        </p>
        <p class="sub">
          <a name="d1e801"> </a>
          <span class="num">
            <span class="holder"> (2) </span>
          </span>
          An applicant is not eligible for enrolment unless the applicant holds
          a business licence, issued by a local government, in respect of the
          site.
        </p>
        <p class="sub">
          <a name="d1e810"> </a>
          <span class="num">
            <span class="holder"> (3) </span>
          </span>
          An applicant is not eligible for enrolment in a device provider
          sub-class referred to in this subsection unless the applicant confirms
          that each person who will be providing benefits through the site is
          appropriately qualified to provide the type of benefit the person will
          be providing, including confirming the following, as applicable:
        </p>
        <p class="para">
          <a name="d1e818"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          in the case of an application for enrolment in the compression garment
          provider sub-class, that compression garment benefits will be provided
          through the site only by a person who has completed training, by a
          compression garment manufacturer, in fitting the type of compression
          garments to be provided;
        </p>
        <p class="para">
          <a name="d1e827"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          in the case of an application for enrolment in the limb prosthesis
          provider sub-class, that limb prosthesis benefits will be provided
          through the site only by a person recognized by the Canadian Board for
          Certification of Prosthetists and Orthotists as a person qualified to
          fit limb prostheses;
        </p>
        <p class="para">
          <a name="d1e836"> </a>
          <span class="num">
            <span class="holder"> (c) </span>
          </span>
          in the case of an application for enrolment in the breast prosthesis
          provider sub-class, that breast prosthesis benefits will be provided
          through the site only by a person who has completed training, by a
          breast prosthesis manufacturer, in fitting breast prostheses;
        </p>
        <p class="para">
          <a name="d1e846"> </a>
          <span class="num">
            <span class="holder"> (d) </span>
          </span>
          in the case of an application for enrolment in the ocular prosthesis
          provider sub-class, that ocular prosthesis benefits will be provided
          through the site only by a person recognized by the National Examining
          Board of Ocularists, Inc. as a person qualified to fit ocular
          prostheses;
        </p>
        <p class="para">
          <a name="d1e855"> </a>
          <span class="num">
            <span class="holder"> (e) </span>
          </span>
          in the case of an application for enrolment in the orthosis provider
          sub-class, that orthosis benefits will be provided through the site
          only by a person recognized by the Canadian Board for Certification of
          Prosthetists and Orthotists as a person qualified to fit orthoses.
        </p>
        <p class="sub">
          <a name="d1e866"> </a>
          <span class="num">
            <span class="holder"> (4) </span>
          </span>
          A person is deemed to be a device provider without applying for
          enrolment, and subsection (2) does not apply, if the person
        </p>
        <p class="para">
          <a name="d1e874"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          is enrolled in the pharmacy provider class, and
        </p>
        <p class="para">
          <a name="d1e883"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          provides through the person's pharmacy devices other than those
          described in subsection (3).
        </p>
        <p class="hnote">
          [am. B.C. Regs. 327/2021, ss. 3 and 4; 76/2022, s. 3.]
        </p>
      </div>
      <div class="section">
        <a name="section5"> </a>
        <h4>
          <a name="section5"> </a>
          Exception
        </h4>
        <p class="sec nosubsecnum" id="d1e895">
          <span class="secnum">
            <span class="secnumholder">
              <b> 5 </b>
            </span>
          </span>
          Despite sections 2 to 4
          <em> [when ineligible for enrolment] </em>
          , the minister may enroll as a provider an applicant who is not
          eligible for enrolment under one or more of those sections if the
          minister is of the opinion that doing so
        </p>
        <p class="para">
          <a name="d1e906"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          would not present a risk to the integrity of the provincial drug
          program, or
        </p>
        <p class="para">
          <a name="d1e915"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          would be in the public interest for any reason, including for the
          purpose of ensuring an adequate supply of benefits to beneficiaries.
        </p>
        <p class="hnote">[am. B.C. Reg. 327/2021, s. 3.]</p>
      </div>
      <div class="section">
        <a name="section6"> </a>
        <h4>
          <a name="section6"> </a>
          Extrajurisdictional applicants
        </h4>
        <p class="sec" id="d1e925">
          <span class="secnum">
            <span class="secnumholder">
              <b> 6 </b>
              <a name="d1e933"> </a>
              (1)
            </span>
          </span>
          Without limiting sections 2 to 4
          <em> [when ineligible for enrolment] </em>
          , an applicant is not eligible for enrolment in respect of a site
          located outside British Columbia unless
        </p>
        <p class="para">
          <a name="d1e941"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          the site that is the subject of the applicant's application is located
          in another province or territory in Canada,
        </p>
        <p class="para">
          <a name="d1e950"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          the applicant provides a signed statement confirming that the
          applicant provides, or intends to provide, drugs, devices, substances
          or related services to residents of British Columbia, and
        </p>
        <p class="para">
          <a name="d1e959"> </a>
          <span class="num">
            <span class="holder"> (c) </span>
          </span>
          the applicant provides a signed statement confirming that the
          applicant
        </p>
        <p class="subpara">
          <a name="d1e967"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          recognizes and is bound by the laws of the Province of British
          Columbia in respect of all matters related to the applicant's
          enrolment and conduct under the Act in respect of the site, and
        </p>
        <p class="subpara">
          <a name="d1e976"> </a>
          <span class="num">
            <span class="holder"> (ii) </span>
          </span>
          agrees that court proceedings in a matter related to the applicant's
          enrolment and conduct under the Act in respect of the site will be
          conducted in a court of the Province of British Columbia.
        </p>
        <p class="sub">
          <a name="d1e987"> </a>
          <span class="num">
            <span class="holder"> (2) </span>
          </span>
          Signed statements under this section must be in the form and manner
          required by the minister.
        </p>
        <p class="hnote">[am. B.C. Regs. 50/2016, s. 11; 327/2021, s. 3.]</p>
      </div>
      <div class="section">
        <a name="section7"> </a>
        <h4>
          <a name="section7"> </a>
          Information required with application
        </h4>
        <p class="sec" id="d1e997">
          <span class="secnum">
            <span class="secnumholder">
              <b> 7 </b>
              <a name="d1e1005"> </a>
              (1)
            </span>
          </span>
          An applicant's application must include all of the following:
        </p>
        <p class="para">
          <a name="d1e1013"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          the applicant's contact information;
        </p>
        <p class="para">
          <a name="d1e1022"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          the operating name and address of, and contact information for, the
          site that is the subject of the application;
        </p>
        <p class="para">
          <a name="d1e1031"> </a>
          <span class="num">
            <span class="holder"> (c) </span>
          </span>
          the names of the owner and manager of the site that is the subject of
          the application, and the owner's contact information;
        </p>
        <p class="para">
          <a name="d1e1041"> </a>
          <span class="num">
            <span class="holder"> (d) </span>
          </span>
          in the case of a corporate applicant,
        </p>
        <p class="subpara">
          <a name="d1e1049"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          a copy of the applicant's power of attorney showing the names and
          contact information of all persons who may exercise a power of
          attorney in respect of the corporation,
        </p>
        <p class="subpara">
          <a name="d1e1058"> </a>
          <span class="num">
            <span class="holder"> (ii) </span>
          </span>
          a BC company summary showing the names and contact information of all
          officers and directors of the applicant,
        </p>
        <p class="subpara">
          <a name="d1e1067"> </a>
          <span class="num">
            <span class="holder"> (iii) </span>
          </span>
          if the applicant is incorporated under a federal enactment, the names
          and contact information of all officers and directors of the
          applicant, and
        </p>
        <p class="subpara">
          <a name="d1e1077"> </a>
          <span class="num">
            <span class="holder"> (iv) </span>
          </span>
          if the applicant is not traded publicly, a copy of the shareholder's
          register and of all shareholder agreements, if any, with respect to
          the operation of the site that is the subject of the application;
        </p>
        <p class="para">
          <a name="d1e1087"> </a>
          <span class="num">
            <span class="holder"> (e) </span>
          </span>
          a copy of the pharmacy licence or business licence, as applicable,
          that has been issued in respect of the site that is the subject of the
          application;
        </p>
        <p class="para">
          <a name="d1e1096"> </a>
          <span class="num">
            <span class="holder"> (f) </span>
          </span>
          in the case of an applicant for enrolment in the opioid agonist
          treatment provider sub-class, confirmation that each pharmacist who
          will be providing drugs, devices, substances or related services
          through the pharmacy that is the subject of the application has
          completed training as required under section 3 (4)
          <em> [enrolment of pharmacy providers] </em>
          ;
        </p>
        <p class="para">
          <a name="d1e1106"> </a>
          <span class="num">
            <span class="holder"> (g) </span>
          </span>
          in the case of an applicant for enrolment in the device provider
          class, confirmation that each person providing benefits through the
          site that is the subject of the application is recognized or has
          completed training as required under section 4 (3)
          <em> [enrolment of device providers] </em>
          ;
        </p>
        <p class="para">
          <a name="d1e1115"> </a>
          <span class="num">
            <span class="holder"> (h) </span>
          </span>
          the operating names of all other sites in respect of which the
          applicant, or an owner of the applicant, is an owner or a manager,
          and, for each site, the site identification code.
        </p>
        <p class="sub">
          <a name="d1e1124"> </a>
          <span class="num">
            <span class="holder"> (2) </span>
          </span>
          An applicant's application must give details of all of the following
          that apply to the applicant:
        </p>
        <p class="para">
          <a name="d1e1132"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          all audits, orders, suspensions or cancellations of billing
          privileges, judgments and convictions referred to in section 2
          <em> [when not eligible for enrolment] </em>
          ;
        </p>
        <p class="para">
          <a name="d1e1141"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          all registration suspensions and cancellations referred to in section
          3 (3);
        </p>
        <p class="para">
          <a name="d1e1150"> </a>
          <span class="num">
            <span class="holder"> (c) </span>
          </span>
          all disciplinary actions taken by a governing body that resulted in
        </p>
        <p class="subpara">
          <a name="d1e1158"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          the imposition of limits or conditions on the practice of pharmacy
          against an owner or a manager of the site that is the subject of the
          application, or
        </p>
        <p class="subpara">
          <a name="d1e1167"> </a>
          <span class="num">
            <span class="holder"> (ii) </span>
          </span>
          the suspension or cancellation of the registration of an owner or a
          manager of the site that is the subject of the application;
        </p>
        <p class="para">
          <a name="d1e1178"> </a>
          <span class="num">
            <span class="holder"> (d) </span>
          </span>
          all actions or proceedings taken by the Canadian Board for
          Certification of Prosthetists and Orthotists that resulted in the
          imposition of limits, conditions or prohibitions on the provision of
          prostheses or orthoses by an owner or a manager of the site that is
          the subject of the application;
        </p>
        <p class="para">
          <a name="d1e1187"> </a>
          <span class="num">
            <span class="holder"> (e) </span>
          </span>
          all instances within the previous 6 years in which an owner of the
          site that is the subject of the application has been the director of a
          corporation that has declared or been petitioned into bankruptcy.
        </p>
        <p class="hnote">
          [am. B.C. Regs. 181/2019, Sch. s. 2; 327/2021, s. 3.]
        </p>
      </div>
      <p class="part" id="d1e1199">
        <a name="part3"> </a>
        Part 3 — Duties of Providers
      </p>
      <div class="section">
        <a name="section8"> </a>
        <h4>
          <a name="section8"> </a>
          Notice of changes generally
        </h4>
        <p class="sec" id="d1e1207">
          <span class="secnum">
            <span class="secnumholder">
              <b> 8 </b>
              <a name="d1e1215"> </a>
              (1)
            </span>
          </span>
          A provider must give to the minister notice of the following changes
          at least 7 days before the change is to occur:
        </p>
        <p class="para">
          <a name="d1e1223"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          if there is a change to the provider's contact information,
        </p>
        <p class="subpara">
          <a name="d1e1231"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          both the current and new contact information,
        </p>
        <p class="subpara">
          <a name="d1e1240"> </a>
          <span class="num">
            <span class="holder"> (ii) </span>
          </span>
          the provider's site identification code or codes, and
        </p>
        <p class="subpara">
          <a name="d1e1249"> </a>
          <span class="num">
            <span class="holder"> (iii) </span>
          </span>
          the date the change is effective;
        </p>
        <p class="para">
          <a name="d1e1259"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          if there is a change to the provider's business or corporate name,
        </p>
        <p class="subpara">
          <a name="d1e1267"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          both the current and new business or corporate names,
        </p>
        <p class="subpara">
          <a name="d1e1276"> </a>
          <span class="num">
            <span class="holder"> (ii) </span>
          </span>
          the provider's site identification code or codes, and
        </p>
        <p class="subpara">
          <a name="d1e1285"> </a>
          <span class="num">
            <span class="holder"> (iii) </span>
          </span>
          the date the change is effective;
        </p>
        <p class="para">
          <a name="d1e1295"> </a>
          <span class="num">
            <span class="holder"> (c) </span>
          </span>
          if there is a change to an owner of a site, other than a change
          resulting from a disposition of ownership,
        </p>
        <p class="subpara">
          <a name="d1e1303"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          the name and address of the site,
        </p>
        <p class="subpara">
          <a name="d1e1312"> </a>
          <span class="num">
            <span class="holder"> (ii) </span>
          </span>
          the name of the current owner,
        </p>
        <p class="subpara">
          <a name="d1e1321"> </a>
          <span class="num">
            <span class="holder"> (iii) </span>
          </span>
          the name and contact information of the new owner,
        </p>
        <p class="subpara">
          <a name="d1e1331"> </a>
          <span class="num">
            <span class="holder"> (iv) </span>
          </span>
          the provider's site identification code or codes, and
        </p>
        <p class="subpara">
          <a name="d1e1340"> </a>
          <span class="num">
            <span class="holder"> (v) </span>
          </span>
          the date the change is effective;
        </p>
        <p class="para">
          <a name="d1e1351"> </a>
          <span class="num">
            <span class="holder"> (d) </span>
          </span>
          if there is a change to the manager of a site,
        </p>
        <p class="subpara">
          <a name="d1e1359"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          the site's name, address and site identification code,
        </p>
        <p class="subpara">
          <a name="d1e1368"> </a>
          <span class="num">
            <span class="holder"> (ii) </span>
          </span>
          the names of both the current and new managers, and
        </p>
        <p class="subpara">
          <a name="d1e1377"> </a>
          <span class="num">
            <span class="holder"> (iii) </span>
          </span>
          the date the change is effective.
        </p>
        <p class="sub">
          <a name="d1e1388"> </a>
          <span class="num">
            <span class="holder"> (2) </span>
          </span>
          A provider must give the following to the minister at least 7 days
          before a change to the location of the site that is the subject of the
          provider's enrolment is to occur:
        </p>
        <p class="para">
          <a name="d1e1396"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          notice of
        </p>
        <p class="subpara">
          <a name="d1e1404"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          the site's name and site identification code,
        </p>
        <p class="subpara">
          <a name="d1e1413"> </a>
          <span class="num">
            <span class="holder"> (ii) </span>
          </span>
          the addresses of both the current and new sites, and
        </p>
        <p class="subpara">
          <a name="d1e1422"> </a>
          <span class="num">
            <span class="holder"> (iii) </span>
          </span>
          the date the change is effective;
        </p>
        <p class="para">
          <a name="d1e1432"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          a copy of the pharmacy licence or business licence for the new site.
        </p>
        <p class="sub">
          <a name="d1e1442"> </a>
          <span class="num">
            <span class="holder"> (3) </span>
          </span>
          In the case of a corporate owner, a provider must give notice of the
          following changes at least 7 days before the change is to occur:
        </p>
        <p class="para">
          <a name="d1e1450"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          a change to the provider's power of attorney;
        </p>
        <p class="para">
          <a name="d1e1459"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          a change to the provider's officers or directors;
        </p>
        <p class="para">
          <a name="d1e1468"> </a>
          <span class="num">
            <span class="holder"> (c) </span>
          </span>
          if the provider is not traded publicly, a change to the corporate
          shareholders.
        </p>
        <p class="sub">
          <a name="d1e1479"> </a>
          <span class="num">
            <span class="holder"> (4) </span>
          </span>
          If notice is given under subsection (3), the provider must also give a
          copy of the following, as applicable, no more than 30 days after the
          change occurred:
        </p>
        <p class="para">
          <a name="d1e1487"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          the power of attorney, showing the names and contact information of
          all persons who may exercise a power of attorney in respect of the
          corporation;
        </p>
        <p class="para">
          <a name="d1e1496"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          either
        </p>
        <p class="subpara">
          <a name="d1e1504"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          a BC company summary showing the names and contact information of all
          officers and directors of the provider, or
        </p>
        <p class="subpara">
          <a name="d1e1513"> </a>
          <span class="num">
            <span class="holder"> (ii) </span>
          </span>
          if the provider is incorporated under a federal enactment, the names
          and contact information of all officers and directors of the provider;
        </p>
        <p class="para">
          <a name="d1e1523"> </a>
          <span class="num">
            <span class="holder"> (c) </span>
          </span>
          the shareholder's register and all shareholder agreements, if any,
          with respect to the operation of the site that is the subject of the
          provider's enrolment.
        </p>
        <p class="hnote">[am. B.C. Reg. 327/2021, s. 3.]</p>
      </div>
      <div class="section">
        <a name="section9"> </a>
        <h4>
          <a name="section9"> </a>
          Notice of service termination
        </h4>
        <p class="sec" id="d1e1534">
          <span class="secnum">
            <span class="secnumholder">
              <b> 9 </b>
              <a name="d1e1542"> </a>
              (1)
            </span>
          </span>
          A pharmacy provider enrolled in the Plan B provider sub-class must
          give to the minister notice of the provider's intention to stop
          providing benefits to beneficiaries enrolled in Plan B no later than
          the last day of the month that falls before the final full month in
          which service will be provided.
        </p>
        <p class="sub">
          <a name="d1e1551"> </a>
          <span class="num">
            <span class="holder"> (2) </span>
          </span>
          A pharmacy provider enrolled in the opioid agonist treatment provider
          sub-class must give to the minister notice of the provider's intention
          to stop providing opioid agonist treatment services at least 30 days
          before services will end.
        </p>
        <p class="sub">
          <a name="d1e1560"> </a>
          <span class="num">
            <span class="holder"> (3) </span>
          </span>
          A device provider enrolled in any sub-class referred to in section 4
          (3)
          <em> [enrolment of device providers] </em>
          must notify the minister as soon as reasonably practicable if the
          device provider's site ceases to be served by a person who is
          appropriately qualified as described by that subsection to provide the
          type of benefits relevant to the sub-class.
        </p>
        <p class="hnote">[am. B.C. Reg. 181/2019, Sch. ss. 2 and 3.]</p>
      </div>
      <div class="section">
        <a name="section10"> </a>
        <h4>
          <a name="section10"> </a>
          Notice of disposition or closure
        </h4>
        <p class="sec" id="d1e1570">
          <span class="secnum">
            <span class="secnumholder">
              <b> 10 </b>
              <a name="d1e1578"> </a>
              (1)
            </span>
          </span>
          A provider who intends to dispose of or close the site that is the
          subject of the provider's enrolment, rather than changing the location
          of the site only, must give to the minister notice of the following at
          least 30 days before the date the disposition or closure is effective:
        </p>
        <p class="para">
          <a name="d1e1586"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          the site's name, address and site identification code;
        </p>
        <p class="para">
          <a name="d1e1595"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          the date the disposition or closure is effective;
        </p>
        <p class="para">
          <a name="d1e1604"> </a>
          <span class="num">
            <span class="holder"> (c) </span>
          </span>
          in the case of a disposition only, the names and contact information
          of both the current and new owners.
        </p>
        <p class="sub">
          <a name="d1e1614"> </a>
          <span class="num">
            <span class="holder"> (2) </span>
          </span>
          Despite section 20
          <em> [changes to requirements, limits or conditions] </em>
          , the minister may not waive or modify the 30 day notice requirement
          referred to in subsection (1) of this section.
        </p>
        <p class="hnote">[am. B.C. Reg. 327/2021, s. 3.]</p>
      </div>
      <div class="section">
        <a name="section11"> </a>
        <h4>
          <a name="section11"> </a>
          Notice of certain actions or events
        </h4>
        <p class="sec nosubsecnum" id="d1e1625">
          <span class="secnum">
            <span class="secnumholder">
              <b> 11 </b>
            </span>
          </span>
          A provider must give notice to the minister immediately if the
          provider, or, in the case of a provider that is a corporation, an
          officer or a director of the provider, becomes subject to, or the
          subject of, any of the following:
        </p>
        <p class="para">
          <a name="d1e1636"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          any of the matters, other than an audit, described in section 7 (2)
          <em> [information required with application] </em>
          ;
        </p>
        <p class="para">
          <a name="d1e1645"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          a requirement to pay an amount to a public insurer as a result of an
          audit conducted in relation to
        </p>
        <p class="subpara">
          <a name="d1e1653"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          the insurer's public drug insurance program, and
        </p>
        <p class="subpara">
          <a name="d1e1662"> </a>
          <span class="num">
            <span class="holder"> (ii) </span>
          </span>
          the site that is the subject of the provider's enrolment.
        </p>
        <p class="hnote">[am. B.C. Reg. 327/2021, s. 3.]</p>
      </div>
      <div class="section">
        <a name="section12"> </a>
        <h4>
          <a name="section12"> </a>
          Requirement to keep records generally
        </h4>
        <p class="sec nosubsecnum" id="d1e1673">
          <span class="secnum">
            <span class="secnumholder">
              <b> 12 </b>
            </span>
          </span>
          Providers must keep all of the following records:
        </p>
        <p class="para">
          <a name="d1e1684"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          original prescriptions and refill authorizations received in respect
          of beneficiaries, showing the information required under section 6
          (2), (4), (7), (9) and (10) of Part 1 of Schedule F to the College of
          Pharmacists bylaws;
        </p>
        <p class="para">
          <a name="d1e1693"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          records respecting the provision of benefits to beneficiaries,
          showing, for each transaction,
        </p>
        <p class="subpara">
          <a name="d1e1701"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          the date,
        </p>
        <p class="subpara">
          <a name="d1e1710"> </a>
          <span class="num">
            <span class="holder"> (ii) </span>
          </span>
          the benefit provided,
        </p>
        <p class="subpara">
          <a name="d1e1719"> </a>
          <span class="num">
            <span class="holder"> (iii) </span>
          </span>
          the beneficiary's name and identity number, and
        </p>
        <p class="subpara">
          <a name="d1e1729"> </a>
          <span class="num">
            <span class="holder"> (iv) </span>
          </span>
          the total amount charged and received;
        </p>
        <p class="para">
          <a name="d1e1740"> </a>
          <span class="num">
            <span class="holder"> (c) </span>
          </span>
          copies of records made or submitted in relation to a claim, including
          copies of any relevant authorizations given by the minister under the
          Act before the claim is made;
        </p>
        <p class="para">
          <a name="d1e1749"> </a>
          <span class="num">
            <span class="holder"> (d) </span>
          </span>
          records of purchase orders and invoices for drugs, devices and
          substances that may be provided as benefits, with each purchase order
          and invoice having a unique identifying number and showing, for each
          purchase,
        </p>
        <p class="subpara">
          <a name="d1e1757"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          the names and contact information of both the vendor and purchaser,
        </p>
        <p class="subpara">
          <a name="d1e1766"> </a>
          <span class="num">
            <span class="holder"> (ii) </span>
          </span>
          the date the drugs, devices or substances were received,
        </p>
        <p class="subpara">
          <a name="d1e1775"> </a>
          <span class="num">
            <span class="holder"> (iii) </span>
          </span>
          the name, strength, unit price, quantity and, if applicable, Drug
          Identification Number, of the drugs, devices and substances, and
        </p>
        <p class="subpara">
          <a name="d1e1785"> </a>
          <span class="num">
            <span class="holder"> (iv) </span>
          </span>
          the total amount charged and paid;
        </p>
        <p class="para">
          <a name="d1e1795"> </a>
          <span class="num">
            <span class="holder"> (e) </span>
          </span>
          records of shipping orders for drugs, devices and substances for which
          there is no purchase order or invoice but in relation to which a
          related service was or is to be provided, with each shipping order
          having a unique identifying number and showing, for each shipment,
        </p>
        <p class="subpara">
          <a name="d1e1803"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          the names and contact information of both the shipper and receiver,
          and
        </p>
        <p class="subpara">
          <a name="d1e1812"> </a>
          <span class="num">
            <span class="holder"> (ii) </span>
          </span>
          the information required under paragraph (d);
        </p>
        <p class="para">
          <a name="d1e1822"> </a>
          <span class="num">
            <span class="holder"> (f) </span>
          </span>
          records of transfers of drugs, devices and substances that may be
          provided as benefits between sites or other locations for which a
          provider is an owner or a manager, showing, for each transfer,
        </p>
        <p class="subpara">
          <a name="d1e1830"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          the name and address of both the site from which the drugs, devices
          and substances were transferred and the site at which the drugs,
          devices and substances were received,
        </p>
        <p class="subpara">
          <a name="d1e1839"> </a>
          <span class="num">
            <span class="holder"> (ii) </span>
          </span>
          the name and signature of the person taking receipt of the transferred
          drugs, devices and substances,
        </p>
        <p class="subpara">
          <a name="d1e1848"> </a>
          <span class="num">
            <span class="holder"> (iii) </span>
          </span>
          the date the transferred drugs, devices or substances were received,
        </p>
        <p class="subpara">
          <a name="d1e1858"> </a>
          <span class="num">
            <span class="holder"> (iv) </span>
          </span>
          the name, strength, unit price, quantity and, if applicable, Drug
          Identification Number or Product Identification Number, of the
          transferred drugs, devices and substances, and
        </p>
        <p class="subpara">
          <a name="d1e1867"> </a>
          <span class="num">
            <span class="holder"> (v) </span>
          </span>
          the total amount charged and paid, if any;
        </p>
        <p class="para">
          <a name="d1e1877"> </a>
          <span class="num">
            <span class="holder"> (g) </span>
          </span>
          records made in relation to the provision of incentives by the
          provider as described in section 51 (2)
          <em> [offences] </em>
          of the Act;
        </p>
        <p class="para">
          <a name="d1e1886"> </a>
          <span class="num">
            <span class="holder"> (h) </span>
          </span>
          copies of records issued by a manufacturer or body respecting
          recognition or training for the purposes of section 4 (3)
          <em> [enrolment of device providers] </em>
          ;
        </p>
        <p class="para">
          <a name="d1e1899"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          records made in relation to the provision of related services by the
          provider, regardless of whether the drug, device or substance to which
          the service is related is a benefit.
        </p>
      </div>
      <div class="section">
        <a name="section13"> </a>
        <h4>
          <a name="section13"> </a>
          Additional records to be kept by pharmacy providers
        </h4>
        <p class="sec" id="d1e1909">
          <span class="secnum">
            <span class="secnumholder">
              <b> 13 </b>
              <a name="d1e1917"> </a>
              (1)
            </span>
          </span>
          In addition to the records required under section 12
          <em> [requirements to keep records generally] </em>
          , a pharmacy provider enrolled in the Plan B provider sub-class must
          keep a record, in respect of each beneficiary served by the provider
          who is enrolled in Plan B, that includes all of the following:
        </p>
        <p class="para">
          <a name="d1e1925"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          the information required under section 13 (2) and (3) of Part 3 of
          Schedule F to the College of Pharmacists bylaws;
        </p>
        <p class="para">
          <a name="d1e1934"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          a record of the review required under section 15 of Part 3 of Schedule
          F to the College of Pharmacists bylaws.
        </p>
        <p class="sub">
          <a name="d1e1944"> </a>
          <span class="num">
            <span class="holder"> (2) </span>
          </span>
          In addition to the records required under section 12, a pharmacy
          provider enrolled in the opioid agonist treatment provider sub-class
          must keep both of the following records in respect of each
          prescription received by the provider in respect of opioid agonist
          treatment services for a beneficiary:
        </p>
        <p class="para">
          <a name="d1e1952"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          the original prescription form as approved by the College of
          Physicians and Surgeons of British Columbia, showing
        </p>
        <p class="subpara">
          <a name="d1e1960"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          the beneficiary's personal health number, name, address and date of
          birth,
        </p>
        <p class="subpara">
          <a name="d1e1969"> </a>
          <span class="num">
            <span class="holder"> (ii) </span>
          </span>
          the name, contact information and identification number, as issued by
          the College of Physicians and Surgeons of British Columbia, of the
          prescriber,
        </p>
        <p class="subpara">
          <a name="d1e1978"> </a>
          <span class="num">
            <span class="holder"> (iii) </span>
          </span>
          the prescription folio number and the date of the prescription,
        </p>
        <p class="subpara">
          <a name="d1e1988"> </a>
          <span class="num">
            <span class="holder"> (iv) </span>
          </span>
          the name of the drug, the strength and quantity prescribed, the
          prescribed daily dose and the dates on which dosing is to begin and
          end,
        </p>
        <p class="subpara">
          <a name="d1e1997"> </a>
          <span class="num">
            <span class="holder"> (v) </span>
          </span>
          whether ingestion must always be witnessed, and, if ingestion need not
          always be witnessed, a statement in both numeric and alphabetical form
          of the number of days each week that ingestion must be witnessed,
        </p>
        <p class="subpara">
          <a name="d1e2006"> </a>
          <span class="num">
            <span class="holder"> (vi) </span>
          </span>
          whether the drug may be delivered to the beneficiary, and
        </p>
        <p class="subpara">
          <a name="d1e2015"> </a>
          <span class="num">
            <span class="holder"> (vii) </span>
          </span>
          the signatures of the prescriber, the dispensing pharmacist and the
          beneficiary;
        </p>
        <p class="para">
          <a name="d1e2025"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          a log showing the beneficiary's name and, for each dispensation,
        </p>
        <p class="subpara">
          <a name="d1e2033"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          the date the drug was dispensed,
        </p>
        <p class="subpara">
          <a name="d1e2042"> </a>
          <span class="num">
            <span class="holder"> (ii) </span>
          </span>
          the prescription or transaction number,
        </p>
        <p class="subpara">
          <a name="d1e2051"> </a>
          <span class="num">
            <span class="holder"> (iii) </span>
          </span>
          the quantity of the drug witnessed as having been ingested, the
          quantity provided for ingestion other than at the pharmacy, if any,
          and the total quantity dispensed,
        </p>
        <p class="subpara">
          <a name="d1e2061"> </a>
          <span class="num">
            <span class="holder"> (iv) </span>
          </span>
          if the drug was provided for delivery to the beneficiary, the address
          to which and the date on which the delivery was made, and
        </p>
        <p class="subpara">
          <a name="d1e2070"> </a>
          <span class="num">
            <span class="holder"> (v) </span>
          </span>
          the signature or initials of the dispensing pharmacist, and the
          signature of the beneficiary, confirming that the drug was dispensed
          on the date indicated under subparagraph (i).
        </p>
        <p class="hnote">[am. B.C. Reg. 181/2019, Sch. ss. 2, 3 and 6.]</p>
      </div>
      <div class="section">
        <a name="section14"> </a>
        <h4>
          <a name="section14"> </a>
          Keeping records
        </h4>
        <p class="sec" id="d1e2082">
          <span class="secnum">
            <span class="secnumholder">
              <b> 14 </b>
              <a name="d1e2090"> </a>
              (1)
            </span>
          </span>
          Records under sections 12
          <em> [requirement to keep records generally] </em>
          and 13
          <em> [additional records to be kept by pharmacy providers] </em>
          must be kept
        </p>
        <p class="para">
          <a name="d1e2098"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          for at least 4 years, or
        </p>
        <p class="para">
          <a name="d1e2107"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          if an inspection or audit is in process in respect of the provider or
          the site that is the subject of the provider's enrolment at the end of
          the 4 year period, until the inspection or audit is complete.
        </p>
        <p class="sub">
          <a name="d1e2117"> </a>
          <span class="num">
            <span class="holder"> (2) </span>
          </span>
          Without limiting section 11 (4) (c)
          <em> [enrolment of providers] </em>
          of the Act, the minister may require a provider to keep records as
          follows:
        </p>
        <p class="para">
          <a name="d1e2125"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          in addition to those listed in sections 12 and 13;
        </p>
        <p class="para">
          <a name="d1e2134"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          for a longer period of time than as set out in subsection (1) of this
          section.
        </p>
        <p class="hnote">[am. B.C. Reg. 327/2021, s. 3.]</p>
      </div>
      <p class="part" id="d1e2146">
        <a name="part4"> </a>
        Part 4 — Benefits and Claims
      </p>
      <div class="section">
        <a name="section15"> </a>
        <h4>
          <a name="section15"> </a>
          Misuse of identity numbers
        </h4>
        <p class="sec nosubsecnum" id="d1e2154">
          <span class="secnum">
            <span class="secnumholder">
              <b> 15 </b>
            </span>
          </span>
          Providers are prescribed as persons who must make a report respecting
          suspected misuse of identity numbers for the purposes of section 15
          <em> [identity numbers] </em>
          of the Act.
        </p>
      </div>
      <div class="section">
        <a name="section16"> </a>
        <h4>
          <a name="section16"> </a>
          Pre-approvals for certain devices
        </h4>
        <p class="sec" id="d1e2169">
          <span class="secnum">
            <span class="secnumholder">
              <b> 16 </b>
              <a name="d1e2177"> </a>
              (1)
            </span>
          </span>
          A device provider must have written approval from the minister before
          providing to a beneficiary a prosthetic or orthotic device that will
          be the subject of a claim for payment under the Act.
        </p>
        <p class="sub">
          <a name="d1e2186"> </a>
          <span class="num">
            <span class="holder"> (2) </span>
          </span>
          Despite subsection (1), the minister may waive approval in respect of
          the following devices:
        </p>
        <p class="para">
          <a name="d1e2194"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          lymphedema arm sleeves, gloves or gauntlets;
        </p>
        <p class="para">
          <a name="d1e2203"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          breast prostheses;
        </p>
        <p class="para">
          <a name="d1e2212"> </a>
          <span class="num">
            <span class="holder"> (c) </span>
          </span>
          post-mastectomy brassieres;
        </p>
        <p class="para">
          <a name="d1e2222"> </a>
          <span class="num">
            <span class="holder"> (d) </span>
          </span>
          plagiocephaly helmets;
        </p>
        <p class="para">
          <a name="d1e2231"> </a>
          <span class="num">
            <span class="holder"> (e) </span>
          </span>
          prosthetic and orthotic supplies, and repairs and adjustments to
          prostheses and orthoses, if the claim is for an amount of less than
          $400;
        </p>
        <p class="para">
          <a name="d1e2484"> </a>
          <span class="num">
            <span class="holder"> (f) </span>
          </span>
          ocular prostheses;
        </p>
        <p class="para">
          <a name="d1e2493"> </a>
          <span class="num">
            <span class="holder"> (g) </span>
          </span>
          ear prostheses;
        </p>
        <p class="para">
          <a name="d1e2504"> </a>
          <span class="num">
            <span class="holder"> (h) </span>
          </span>
          nose prostheses;
        </p>
        <p class="para">
          <a name="d1e2513"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          hip abduction orthoses.
        </p>
        <p class="sub">
          <a name="d1e2241"> </a>
          <span class="num">
            <span class="holder"> (3) </span>
          </span>
          A waiver under subsection (2) may be in respect of a beneficiary or
          class of beneficiaries, or a device or class of devices.
        </p>
        <p class="sub">
          <a name="d1e2251"> </a>
          <span class="num">
            <span class="holder"> (4) </span>
          </span>
          Claims in respect of a prosthetic or an orthotic device for which
          approval is required under this section may be submitted to the
          minister for payment under the Act
        </p>
        <p class="para">
          <a name="d1e2260"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          only after the device is provided to the patient and all related
          services are complete, and
        </p>
        <p class="para">
          <a name="d1e2269"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          no later than 6 months after approval is received, if submitted by a
          provider having access to PharmaNet, as that term is defined in the
          Information Management Regulation.
        </p>
        <p class="sub">
          <a name="d1e2278"> </a>
          <span class="num">
            <span class="holder"> (5) </span>
          </span>
          If a device for which approval was received is not provided, and all
          related services are not complete, within 6 months of receiving
          approval, the approval expires and a new approval must be sought.
        </p>
        <p class="hnote">[am. B.C. Regs. 74/2015, Sch. 3; 72/2020.]</p>
      </div>
      <div class="section">
        <a name="section17"> </a>
        <h4>
          <a name="section17"> </a>
          Amount of claims and charges
        </h4>
        <p class="sec" id="d1e2288">
          <span class="secnum">
            <span class="secnumholder">
              <b> 17 </b>
              <a name="d1e2296"> </a>
              (1)
            </span>
          </span>
          A provider must not claim from the minister payment for a benefit in
          an amount greater than the provider would charge to any other person
          for the drug, device, substance or related service that is the subject
          of the claim.
        </p>
        <p class="sub">
          <a name="d1e2305"> </a>
          <span class="num">
            <span class="holder"> (2) </span>
          </span>
          Subsection (1) does not apply in respect of a discount given to
        </p>
        <p class="para">
          <a name="d1e2313"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          an employee of the provider, or
        </p>
        <p class="para">
          <a name="d1e2322"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          a private insurer within the meaning of section 43
          <em> [sharing information for compliance purposes] </em>
          of the Act.
        </p>
        <p class="sub">
          <a name="d1e2332"> </a>
          <span class="num">
            <span class="holder"> (3) </span>
          </span>
          A provider must not charge a beneficiary any amount in respect of a
          benefit that is a drug, substance or related service for which the
          beneficiary is eligible under a drug plan to have full payment made by
          the minister, except for the following:
        </p>
        <p class="para">
          <a name="d1e2340"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          insulin;
        </p>
        <p class="para">
          <a name="d1e2349"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          nutritional vitamins or supplements for persons suffering from cystic
          fibrosis.
        </p>
      </div>
      <div class="section">
        <a name="section18"> </a>
        <h4>
          <a name="section18"> </a>
          Alternate payees
        </h4>
        <p class="sec" id="d1e2361">
          <span class="secnum">
            <span class="secnumholder">
              <b> 18 </b>
              <a name="d1e2369"> </a>
              (1)
            </span>
          </span>
          A medical practitioner is prescribed under section 17 (2)
          <em> [payments] </em>
          of the Act for the purposes of receiving payments for claims if
        </p>
        <p class="para">
          <a name="d1e2377"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          the College of Physicians and Surgeons of British Columbia identifies
          the medical practitioner to the minister as a person who should be
          receiving payments for claims, and
        </p>
        <p class="para">
          <a name="d1e2386"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          the minister is satisfied that it would be in the public interest for
          the medical practitioner to receive payments for claims, because
        </p>
        <p class="subpara">
          <a name="d1e2394"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          the medical practitioner practises medicine in a remote location that
          is under-served by providers, or
        </p>
        <p class="subpara">
          <a name="d1e2403"> </a>
          <span class="num">
            <span class="holder"> (ii) </span>
          </span>
          for any other reason.
        </p>
        <p class="sub">
          <a name="d1e2414"> </a>
          <span class="num">
            <span class="holder"> (2) </span>
          </span>
          Repealed. [B.C. Reg. 266/2016, Sch. 1, s. 2.]
        </p>
        <p class="hnote">[am. B.C. Reg. 266/2016, Sch. 1, s. 2.]</p>
      </div>
      <div class="section">
        <a name="section19"> </a>
        <h4>
          <a name="section19"> </a>
          Claims for witnessing ingestion
        </h4>
        <p class="sec nosubsecnum" id="d1e2424">
          <span class="secnum">
            <span class="secnumholder">
              <b> 19 </b>
            </span>
          </span>
          A pharmacy provider enrolled in the opioid agonist treatment provider
          sub-class may submit to the minister for payment under the Act a claim
          in relation to witnessing the ingestion of a drug for opioid agonist
          treatment only if a pharmacist described in section 3&nbsp;(4)
          <em> [enrolment of pharmacy providers] </em>
          personally witnesses the ingestion.
        </p>
        <p class="hnote">[am. B.C. Reg. 181/2019, Sch. ss. 2 and 7.]</p>
      </div>
      <p class="part" id="d1e2440">
        <a name="part5"> </a>
        Part 5 — Administration and Enforcement
      </p>
      <div class="section">
        <a name="section20"> </a>
        <h4>
          <a name="section20"> </a>
          Changes to requirements, limits or conditions
        </h4>
        <p class="sec" id="d1e2448">
          <span class="secnum">
            <span class="secnumholder">
              <b> 20 </b>
              <a name="d1e2456"> </a>
              (1)
            </span>
          </span>
          Subject to this section, the minister may waive or modify one or more
          requirements, limits or conditions set under any of sections 2 to 4, 7
          to 9, 12 (a), 13 and 19.
        </p>
        <p class="sub">
          <a name="d1e2465"> </a>
          <span class="num">
            <span class="holder"> (2) </span>
          </span>
          A waiver or modification must be for one or more of the following
          reasons:
        </p>
        <p class="para">
          <a name="d1e2473"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          in the case of an extrajurisdictional applicant or provider, to apply
          equivalent requirements, limits or conditions, or to substitute
          different requirements, limits or conditions, from the province or
          territory in which the site that is the subject of the applicant's
          application is located;
        </p>
        <p class="para">
          <a name="d1e2482"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          in any case,
        </p>
        <p class="subpara">
          <a name="d1e2490"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          if complying with the requirement, limit or condition would not be
          reasonably practical in the circumstances, or
        </p>
        <p class="subpara">
          <a name="d1e2499"> </a>
          <span class="num">
            <span class="holder"> (ii) </span>
          </span>
          if the minister is of the opinion that the waiver or modification
          would be in the public interest for any reason.
        </p>
        <p class="sub">
          <a name="d1e2510"> </a>
          <span class="num">
            <span class="holder"> (3) </span>
          </span>
          A waiver or modification
        </p>
        <p class="para">
          <a name="d1e2518"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          may be in respect of a person or class of persons, and
        </p>
        <p class="para">
          <a name="d1e2527"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          must be in writing.
        </p>
        <p class="hnote">[am. B.C. Reg. 113/2020.]</p>
      </div>
      <div class="section">
        <a name="section21"> </a>
        <h4>
          <a name="section21"> </a>
          Giving information to the minister
        </h4>
        <p class="sec" id="d1e2538">
          <span class="secnum">
            <span class="secnumholder">
              <b> 21 </b>
              <a name="d1e2546"> </a>
              (1)
            </span>
          </span>
          Nothing in this regulation limits the power of the minister to request
          additional information under section 30 (4)
          <em> [applications, notices, hearings, information or reports] </em>
          of the Act.
        </p>
        <p class="sub">
          <a name="d1e2558"> </a>
          <span class="num">
            <span class="holder"> (2) </span>
          </span>
          On request of the minister, a person who makes an application or gives
          to the minister a notice, record, report or other information under
          this regulation must give further details or proof of the matters
          referred to in the application, notice, record, report or other
          information.
        </p>
        <p class="sub">
          <a name="d1e2567"> </a>
          <span class="num">
            <span class="holder"> (3) </span>
          </span>
          A request under subsection (2)
        </p>
        <p class="para">
          <a name="d1e2575"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          may be in respect of a person or class of persons, and
        </p>
        <p class="para">
          <a name="d1e2584"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          must be in writing.
        </p>
      </div>
      <div class="section">
        <a name="section22"> </a>
        <h4>
          <a name="section22"> </a>
          Suspension of payments
        </h4>
        <p class="sec" id="d1e2595">
          <span class="secnum">
            <span class="secnumholder">
              <b> 22 </b>
              <a name="d1e2603"> </a>
              (1)
            </span>
          </span>
          For the purposes of section 45 (1) (a) (ii)
          <em> [suspension of payments] </em>
          of the Act, the prescribed offences are as follows:
        </p>
        <p class="para">
          <a name="d1e2614"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          sections 362, 366, 380, 388, 389, 392, 397, 402, 402.2, 403 and 408
          <em> [fraud] </em>
          of the
          <a href="http://laws-lois.justice.gc.ca/eng/acts/C-46/">
            <em> Criminal Code </em>
          </a>
          ;
        </p>
        <p class="para">
          <a name="d1e2623"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          section 5
          <em> [trafficking] </em>
          of the
          <a href="http://laws-lois.justice.gc.ca/eng/acts/C-38.8/index.html">
            <em> Controlled Drugs and Substances Act </em>
          </a>
          (Canada);
        </p>
        <p class="para">
          <a name="d1e2635"> </a>
          <span class="num">
            <span class="holder"> (c) </span>
          </span>
          section 46 of the
          <a href="http://laws-lois.justice.gc.ca/eng/acts/C-38.8/index.html">
            <em> Controlled Drugs and Substances Act </em>
          </a>
          (Canada), as it relates to a contravention of any provision of
        </p>
        <p class="subpara">
          <a name="d1e2643"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          Part 2
          <em>
            [permitted activities and general obligations of pharmacists]
          </em>
          of the Benzodiazepines and Other Targeted Substances Regulations
          (Canada), SOR/2000-217, or
        </p>
        <p class="subpara">
          <a name="d1e2655"> </a>
          <span class="num">
            <span class="holder"> (ii) </span>
          </span>
          sections 30 to 45 of the Narcotic Control Regulations (Canada),
          C.R.C., c. 1041.
        </p>
        <p class="sub">
          <a name="d1e2666"> </a>
          <span class="num">
            <span class="holder"> (2) </span>
          </span>
          For the purposes of section 45 (1) (b) of the Act, the prescribed
          circumstances are as follows:
        </p>
        <p class="para">
          <a name="d1e2674"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          if the provider is a corporation and an officer or a director of the
          provider has been convicted of an offence referred to in subsection
          (1) of this section;
        </p>
        <p class="para">
          <a name="d1e2683"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          if a provider becomes ineligible to be enrolled as a provider, except
          in the circumstances described in section 2 (2) (a) or (e) (i) or (ii)
          <em> [when not eligible for enrolment] </em>
          ;
        </p>
        <p class="para">
          <a name="d1e2695"> </a>
          <span class="num">
            <span class="holder"> (c) </span>
          </span>
          in the case of a pharmacy provider enrolled in the opioid agonist
          treatment provider sub-class, if the pharmacy provider's site is no
          longer served by pharmacists who are appropriately qualified as
          described in section 3 (4)
          <em> [enrolment of pharmacy providers] </em>
          ;
        </p>
        <p class="para">
          <a name="d1e2708"> </a>
          <span class="num">
            <span class="holder"> (d) </span>
          </span>
          in the case of a device provider enrolled in a sub-class referred to
          in section 4 (3)
          <em> [enrolment of device providers] </em>
          , if the device provider's site is no longer served by a person who is
          appropriately qualified as described by that section to provide the
          type of benefits relevant to the sub-class.
        </p>
        <p class="sub">
          <a name="d1e2721"> </a>
          <span class="num">
            <span class="holder"> (3) </span>
          </span>
          If a provider is enrolled in more than one sub-class, suspension of
          payments in the circumstances described in
        </p>
        <p class="para">
          <a name="d1e2729"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          subsection (2) (c) may only be in respect of claims related to the
          provision of opioid agonist treatment services, and
        </p>
        <p class="para">
          <a name="d1e2738"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          subsection (2) (d) may only be in respect of claims related to the
          provision of benefits relevant to the sub-class for which the device
          provider's site is no longer served by an appropriately qualified
          person.
        </p>
        <p class="hnote">
          [am. B.C. Reg. 181/2019, Sch. ss. 2, 3 and 8 and s. (b), as am. by
          B.C. Reg. 77/2021, s. (c).]
        </p>
      </div>
      <div class="section">
        <a name="section23"> </a>
        <h4>
          <a name="section23"> </a>
          Giving notice of ministerial action
        </h4>
        <p class="sec" id="d1e2750">
          <span class="secnum">
            <span class="secnumholder">
              <b> 23 </b>
              <a name="d1e2758"> </a>
              (1)
            </span>
          </span>
          The minister must give to an applicant for enrolment as a provider
          notice of an intention to deny the application.
        </p>
        <p class="sub">
          <a name="d1e2767"> </a>
          <span class="num">
            <span class="holder"> (2) </span>
          </span>
          The minister must give to a provider notice of the following:
        </p>
        <p class="para">
          <a name="d1e2775"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          an intention to change or cancel the provider's designation or
          enrolment under section 13 (2)
          <em> [changing or cancelling provider enrolment] </em>
          of the Act;
        </p>
        <p class="para">
          <a name="d1e2784"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          an intention to change or add limits and conditions on a provider's
          enrolment under section 13 (3) of the Act.
        </p>
        <p class="sub">
          <a name="d1e2794"> </a>
          <span class="num">
            <span class="holder"> (3) </span>
          </span>
          A notice described in subsection (1) or (2) of this section, or as
          required under section 45 (2) of the Act in respect of a suspension of
          payments, may be given
        </p>
        <p class="para">
          <a name="d1e2802"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          personally, or
        </p>
        <p class="para">
          <a name="d1e2811"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          by registered mail or electronically at the last known business
          address of the applicant or provider.
        </p>
        <p class="sub">
          <a name="d1e2822"> </a>
          <span class="num">
            <span class="holder"> (4) </span>
          </span>
          Despite subsection (3), the minister may waive a requirement for
          notice or provide notice in an alternate fashion if it is not
          reasonably practical to give notice in accordance with that
          subsection.
        </p>
        <p class="sub">
          <a name="d1e2831"> </a>
          <span class="num">
            <span class="holder"> (5) </span>
          </span>
          A notice must include
        </p>
        <p class="para">
          <a name="d1e2839"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          the reasons for the denial, change, cancellation, addition or
          suspension, and
        </p>
        <p class="para">
          <a name="d1e2848"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          in the case of a notice issued under subsection (1), (2) (a) or (3), a
          statement that
        </p>
        <p class="subpara">
          <a name="d1e2856"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          the applicant or provider has 21 days to make a response, in writing,
          to the denial, change, cancellation or suspension, and
        </p>
        <p class="subpara">
          <a name="d1e2865"> </a>
          <span class="num">
            <span class="holder"> (ii) </span>
          </span>
          if the applicant or provider does not make a response, in writing and
          within the 21 day period, the applicant or provider will be given no
          further opportunity to be heard.
        </p>
        <p class="hnote">[am. B.C. Reg. 327/2021, s. 3.]</p>
      </div>
      <div class="section">
        <a name="section24"> </a>
        <h4>
          <a name="section24"> </a>
          Responding to notice of ministerial action
        </h4>
        <p class="sec" id="d1e2877">
          <span class="secnum">
            <span class="secnumholder">
              <b> 24 </b>
              <a name="d1e2885"> </a>
              (1)
            </span>
          </span>
          An applicant or a provider who receives a notice issued under section
          23 (1), (2) (a) or (3)
          <em> [giving notice of ministerial action] </em>
          may respond to the notice by delivering to the minister, within the
          period set out in the notice,
        </p>
        <p class="para">
          <a name="d1e2893"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          a written submission respecting why the minister
        </p>
        <p class="subpara">
          <a name="d1e2901"> </a>
          <span class="num">
            <span class="holder"> (i) </span>
          </span>
          should accept the applicant's application for enrolment,
        </p>
        <p class="subpara">
          <a name="d1e2910"> </a>
          <span class="num">
            <span class="holder"> (ii) </span>
          </span>
          should not change or cancel the provider's enrolment, or
        </p>
        <p class="subpara">
          <a name="d1e2927"> </a>
          <span class="num">
            <span class="holder"> (iii) </span>
          </span>
          should resume payments to the provider,
        </p>
        <p class="para sandwich">as applicable, and</p>
        <p class="para">
          <a name="d1e2939"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          any relevant records or other evidence to support the position of the
          applicant or provider.
        </p>
        <p class="sub">
          <a name="d1e2949"> </a>
          <span class="num">
            <span class="holder"> (2) </span>
          </span>
          On receipt of a response in accordance with subsection (1), the
          minister
        </p>
        <p class="para">
          <a name="d1e2957"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          must consider the submission, records and evidence provided,
        </p>
        <p class="para">
          <a name="d1e2966"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          may vary, confirm or reverse the decision to deny the applicant's
          enrolment, change or cancel the provider's enrolment, or take any
          action the minister must or may take under section 45 of the Act, as
          applicable, and
        </p>
        <p class="para">
          <a name="d1e2975"> </a>
          <span class="num">
            <span class="holder"> (c) </span>
          </span>
          must give notice to the applicant or provider of the decision or
          action taken under paragraph (b) of this subsection.
        </p>
        <p class="hnote">[am. B.C. Reg. 327/2021, s. 3.]</p>
      </div>
      <div class="section">
        <a name="section25"> </a>
        <h4>
          <a name="section25"> </a>
          Deemed receipt of notices
        </h4>
        <p class="sec nosubsecnum" id="d1e2986">
          <span class="secnum">
            <span class="secnumholder">
              <b> 25 </b>
            </span>
          </span>
          A notice given by the minister under the Act is deemed to have been
          received as follows:
        </p>
        <p class="para">
          <a name="d1e2997"> </a>
          <span class="num">
            <span class="holder"> (a) </span>
          </span>
          if sent by registered mail or any other form of delivery, other than
          personally or electronically, 3 days after the date the notice was
          sent;
        </p>
        <p class="para">
          <a name="d1e3006"> </a>
          <span class="num">
            <span class="holder"> (b) </span>
          </span>
          if sent electronically, 24 hours after the time the notice was sent.
        </p>
      </div>
      <p class="provisionsnote">
        [Provisions relevant to the enactment of this regulation:
        <a href="/civix/document/id/complete/statreg/12022_01">
          <em> Pharmaceutical Services Act </em>
        </a>
        , S.B.C. 2012, c. 22, ss. 61 (1), (4) and (5), 62 (1), 63, 64 and 65.]
      </p>
    </div>
  </body>
</html>
